At1g11710 Antibody

What is the At1g11710 antibody and what does it target?

The At1g11710 antibody is a research tool developed to detect the protein encoded by the At1g11710 gene in Arabidopsis thaliana. This antibody recognizes specific epitopes in the target protein, which functions within the angiotensin-related pathway in plants. The target protein shares structural similarities with the human Angiotensin II Receptor Type 1 (AT1R), although they have distinct functions across plant and animal kingdoms . Methodologically, researchers should validate antibody specificity using multiple approaches including western blot with positive and negative controls, as cross-reactivity with other plant proteins can occur due to conserved domains.

What are the recommended validation methods for At1g11710 antibody before experimental use?

To ensure reliable experimental results, researchers should validate the At1g11710 antibody through:

• Western blotting using wild-type plants and At1g11710 knockout mutants

• Immunoprecipitation followed by mass spectrometry

• Preabsorption tests with the immunizing peptide

• Cross-validation with orthogonal methods (e.g., RNA expression data)

• Testing on tissues/samples where the target is known to be expressed vs. absent

These validation approaches help establish specificity and sensitivity parameters, crucial for interpreting experimental outcomes . Researchers should document validation results thoroughly, as antibody performance can vary between experimental conditions and applications.

How should At1g11710 antibody be stored to maintain optimal performance?

For optimal antibody performance, store the primary At1g11710 antibody in small aliquots (20-50 μL) at -80°C for long-term storage, with working aliquots kept at -20°C. Avoid repeated freeze-thaw cycles as this can lead to protein denaturation and reduced antibody activity. When storing diluted working solutions, include carrier proteins (0.5-1% BSA) and preservatives (0.02% sodium azide) to prevent protein adsorption to container surfaces and microbial contamination. Methodologically, researchers should periodically validate stored antibodies against fresh standards to ensure consistent performance across experiments .

What are the optimal conditions for using At1g11710 antibody in immunoblotting?

For successful immunoblotting with At1g11710 antibody, researchers should optimize:

Methodologically, researchers should always include positive controls (recombinant At1g11710 protein or extracts from tissues known to express the target) and negative controls (knockout mutant extracts) .

How can At1g11710 antibody be effectively used in immunoprecipitation studies?

For immunoprecipitation (IP) with At1g11710 antibody, researchers should:

• Pre-clear lysates with protein A/G beads to reduce non-specific binding

• Ensure antibody-to-protein ratio is optimized (typically 2-5 μg antibody per 500 μg total protein)

• Include appropriate controls: no-antibody control, isotype control, and input samples

• Consider cross-linking the antibody to beads to prevent co-elution with the target protein

• Use gentle elution conditions to maintain protein-protein interactions if studying complexes

Methodologically, researchers should validate IP results by immunoblotting a small fraction of the immunoprecipitate and comparing it to input and flow-through samples. For interaction studies, reciprocal co-IP with antibodies against suspected interaction partners provides stronger evidence of protein-protein interactions .

What are the key considerations when designing immunohistochemistry experiments with At1g11710 antibody?

When performing immunohistochemistry with At1g11710 antibody, researchers should consider:

• Fixation method: Aldehydes (e.g., 4% paraformaldehyde) preserve structure but may mask epitopes; test multiple fixation protocols

• Antigen retrieval: Heat-induced epitope retrieval (citrate buffer, pH 6.0) or enzymatic retrieval may be necessary to expose masked epitopes

• Blocking parameters: Use 5-10% normal serum from the same species as the secondary antibody

• Controls: Include tissue from knockout plants, secondary-only controls, and competitive peptide blocking

• Signal amplification: Consider tyramide signal amplification for low-abundance targets

Methodologically, researchers should optimize each step for the specific tissue being examined, as fixation and permeabilization requirements vary between leaf, root, and reproductive tissues. Document all optimization steps to ensure reproducibility .

How can At1g11710 antibody be applied in studying protein-protein interactions?

For investigating protein-protein interactions involving the At1g11710 protein, researchers can employ:

• Co-immunoprecipitation followed by mass spectrometry to identify novel interaction partners

• Proximity ligation assays (PLA) to visualize and quantify interactions in situ

• Bimolecular Fluorescence Complementation (BiFC) as a complementary approach

• FRET/FLIM analyses when combined with fluorescently tagged potential partners

Methodologically, researchers should validate interactions through multiple independent techniques, as each method has limitations. For instance, co-IP may detect indirect interactions within larger complexes, while PLA provides spatial information but requires careful optimization of primary antibody combinations .

What approaches are effective for quantifying At1g11710 protein levels in comparative studies?

For accurate quantification of At1g11710 protein levels across experimental conditions, researchers should:

• Employ quantitative western blotting using:

  • Standardized loading controls (constitutively expressed proteins)

  • Linear range determination for both target and loading control

  • Digital image acquisition with appropriate exposure times

• Consider ELISA-based approaches:

  • Develop a sandwich ELISA using distinct antibodies recognizing different epitopes

  • Include standard curves with recombinant At1g11710 protein

  • Validate the assay's dynamic range and limit of detection

• For absolute quantification:

  • Use stable isotope-labeled peptide standards in targeted mass spectrometry

  • Select multiple peptides unique to the At1g11710 protein

  • Account for extraction efficiency through spike-in controls

Methodologically, researchers should employ statistical approaches appropriate for the experimental design, including technical and biological replicates to assess variability .

How can phosphorylation status of At1g11710 be monitored using antibody-based approaches?

To investigate post-translational modifications of the At1g11710 protein, particularly phosphorylation, researchers may:

• Use phospho-specific antibodies developed against predicted phosphorylation sites

• Employ strategies to preserve phosphorylation during extraction:

  • Include phosphatase inhibitors (sodium fluoride, sodium orthovanadate)

  • Maintain cold temperatures throughout processing

  • Consider denaturing conditions to inactivate endogenous phosphatases

• Validate phosphorylation sites through:

  • Lambda phosphatase treatment as a negative control

  • Parallel mass spectrometry analysis

  • Mutational analysis of predicted phosphorylation sites

Methodologically, researchers should consider enrichment strategies such as phospho-protein enrichment columns or phospho-peptide enrichment (TiO₂, IMAC) prior to analysis, especially for low-abundance proteins like At1g11710 .

What are common causes of false positive or negative results when using At1g11710 antibody?

When working with At1g11710 antibody, researchers should be aware of potential sources of error:

False Positives:

• Cross-reactivity with structurally similar proteins, particularly other members of the same protein family

• Non-specific binding to high-abundance proteins

• Insufficient blocking or inadequate washing steps

• Sample contamination during processing

False Negatives:

• Epitope masking due to protein conformation or post-translational modifications

• Protein degradation during sample preparation

• Insufficient antigen retrieval in fixed tissues

• Suboptimal antibody concentration or incubation conditions

Methodologically, researchers should include appropriate controls to distinguish true signals from artifacts, including knockout/knockdown samples, competitive peptide blocking, and validation with alternative antibodies or detection methods .

How can discrepancies between antibody-based detection and transcript levels of At1g11710 be reconciled?

Discrepancies between protein and mRNA levels are common in biological systems and may indicate important regulatory mechanisms. When encountering such discrepancies for At1g11710, researchers should consider:

• Post-transcriptional regulation:

  • miRNA-mediated suppression

  • Alternative splicing producing isoforms not recognized by the antibody

  • mRNA stability factors

• Post-translational regulation:

  • Protein half-life and degradation rates

  • Subcellular localization affecting extraction efficiency

  • Protein complex formation masking epitopes

• Technical considerations:

  • Different sensitivities of detection methods

  • Timing differences in sample collection

  • Extraction efficiency differences between RNA and protein

Methodologically, researchers should employ time-course experiments, protein synthesis/degradation inhibitors, and multiple detection methods to investigate the underlying mechanisms of observed discrepancies .

What approaches can resolve antibody specificity concerns in At1g11710 research?

When specificity concerns arise with At1g11710 antibody, researchers can implement:

• Genetic validation approaches:

  • Testing on knockout/knockdown lines of At1g11710

  • Complementation with tagged versions of the protein

  • CRISPR-edited epitope tags in the endogenous locus

• Biochemical validation:

  • Immunodepletion using recombinant At1g11710 protein

  • Mass spectrometry identification of immunoprecipitated proteins

  • Peptide array mapping to identify the exact epitope recognized

• Orthogonal method comparison:

  • Correlation with fluorescent protein fusion localization

  • Agreement with protein levels detected by mass spectrometry

  • Concordance with expected developmental or stress-responsive expression patterns

Methodologically, researchers should document and report antibody validation data according to antibody reporting guidelines to improve experimental reproducibility across laboratories .

How can At1g11710 antibody be utilized in high-throughput plant phenotyping studies?

For integrating At1g11710 protein analysis into high-throughput phenotyping, researchers can:

• Develop automated immunoblotting systems for processing multiple samples

• Adapt antibody-based assays to microplate formats for rapid quantification

• Combine with image-based phenotyping to correlate protein levels with morphological traits

• Create biosensor systems using antibody fragments for continuous monitoring

Methodologically, researchers must standardize sample collection, processing, and analysis workflows to ensure comparability across large sample sets. Statistical approaches for handling large datasets, including appropriate normalization methods and accounting for batch effects, are essential for reliable interpretation .

What considerations are important when designing active learning experiments for improving At1g11710 antibody specificity?

Active learning approaches can optimize antibody development through:

• Iterative testing cycles that systematically explore:

  • Epitope selection and refinement

  • Affinity maturation strategies

  • Cross-reactivity reduction

• Implementation of model-based strategies:

  • Using protein structure prediction to identify accessible epitopes

  • Employing machine learning to predict antibody-antigen interactions

  • Applying uncertainty-based selection of test conditions

• Experimental design considerations:

  • Diverse antigen variant testing to ensure broad recognition

  • Structural analysis of epitope conservation across related species

  • Systematic evaluation of potential cross-reactants

Methodologically, researchers should document the decision-making process at each iteration, maintain comprehensive datasets of experimental results, and use statistical approaches to evaluate improvements in specificity and sensitivity metrics .

How might At1g11710 antibody research contribute to understanding plant-pathogen interactions?

The At1g11710 protein's potential role in plant immune responses can be investigated through:

• Spatiotemporal profiling approaches:

  • Time-course analysis of protein levels during pathogen challenge

  • Tissue-specific and subcellular localization changes upon infection

  • Co-localization with known defense signaling components

• Functional studies:

  • Immunoprecipitation of At1g11710 protein complexes before and after pathogen exposure

  • Antibody-based inhibition of protein function in ex vivo systems

  • Correlation of protein levels with resistance phenotypes

• Translational approaches:

  • Comparative analysis across plant species with varying disease susceptibility

  • Identification of At1g11710 modifications associated with activated defense responses

  • Development of diagnostic tools for monitoring plant immune status

Methodologically, researchers should employ experimental designs that include appropriate pathogen controls, timing considerations for defense responses, and integration with other defense-related markers to establish the significance of At1g11710 in plant immunity .